Nick is an associate in the Commercialisation team, advising on commercial and regulatory matters within the life sciences and healthcare sector.
Nick has experience working on a range of matters that includes the commercialisation of intellectual property rights, resolving contractual issues, undertaking corporate due diligence and responding to regulatory and compliance questions.
Advising Rockpool Investments on its acquisition on orthoses and clinical services provider Talar-Made Ltd.
Press releaseWe have advised Sullivan Street Partners and The UKAT Group on UKAT's acquisition of The Providence Projects, one of the country's oldest and most respected rehabilitation centres.
Press releaseWe have advised a syndicate of leading global life sciences investors including Access Biotechnology, Canaan Partners and SR One on their landmark US$140 million series A investment in Draig Therapeutics.
Press releaseOur team has advised Hims & Hers Health, Inc. (NYSE: HIMS), a leading US digital health and wellness company based in San Francisco, on its agreement to acquire ZAVA Global GmbH, one of the market-leading digital health platforms and telemedicine providers in Europe.
Press releaseWe have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its acquisition of UK Addiction Treatment Group (UKAT), the UK’s leading, residential addiction treatment group.
Press releaseAdvising Cumulus Oncology on its collaboration agreement with leadXpro to develop small molecules against GPR68, an important proton sensing G protein coupled receptor.
Press release
作者
The Procurement Act 2023: life sciences and procurement
作者 Matt Evans 以及 Nicholas Vollers
作者 Mareike Christine Gehrmann 以及 Carla Nelles, LL.M. (Amsterdam)
作者 Katie Chandler 以及 Esha Marwaha
作者 Graham Hann 以及 Kelly Burke
作者
作者